Lykan opens manufacturing facility for cell therapies

By The Science Advisory Board staff writers

September 17, 2020 -- Lykan Bioscience has opened a new 64,000-sq-ft "smart" manufacturing facility in Hopkinton, MA.

The facility will supply advanced therapy medicines for oncology, immunology, and hematology applications, the company said.

Smart manufacturing is a computer-integrated manufacturing model that uses digital information technology and includes technical workforce training.

Takeda opens new cell therapy manufacturing facility
Takeda Pharmaceuticals said it has opened a new 24,000-sq-ft research and development (R&D) cell therapy manufacturing facility at its R&D headquarters...
MilliporeSigma expands antibody-drug conjugate manufacturing
MilliporeSigma is expanding its high-potent active pharmaceutical ingredient and antibody-drug conjugate manufacturing capabilities with a $65 million...
Thermo Fisher opens new bioprocessing collaboration center
Thermo Fisher Scientific has opened a new bioprocessing collaboration center in St. Louis to accelerate innovations in biologics manufacturing.
Irisys to manufacture Qualigen COVID-19 drug
Qualigen Therapeutics has signed a contract with Irisys for the production of AS1411, Qualigen's lead candidate for the treatment of viral diseases including...
Thermo Fisher opens manufacturing site for COVID-19 viral transport media
Thermo Fisher Scientific has opened its new $40 million facility in Lenexa, KS, dedicated to viral transport media production. The groundbreaking...

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter